Klick Health Launches First AI Social Media Comment Moderator for Life Sciences Industry
AIT365 News Desk -
KCM+AI provides pharma brands with enhanced handling of pharmacovigilance issues via 24/7 monitoring and automatic comment-holding
Klick Health launched Klick Comment Moderator+AI (KCM+AI), the life sciences industry’s first social media comment moderator powered by artificial intelligence. KCM+AI is powered by Microsoft Azure AI and a proprietary Klick model trained on almost...
Ordaōs Acquires the Carterra®LSA® Platform to Further Speed and Optimize Its Machine-Driven Drug Design System
AIT365 News Desk -
Carterra technology will allow Ordaōs to accelerate its mission of leveraging advanced technologies to efficiently and effectively design novel life-changing therapies for patients in need.
Ordaōs, a human-enabled, machine-driven drug design company that creates novel and customized mini-proteins, announced it has acquired an LSA platform from Carterra, a leading provider...
The Jackson Laboratory and LG AI Research partner to pioneer biomedical advancements
AIT365 News Desk -
Two world-leading organizations are partnering to further expand AI capabilities in biomedical science and catalyze medical progress.
What can happen when prominent institutions in technology and research form a partnership to accelerate the implementation of artificial intelligence (AI) to enhance biomedical research and clinical care? A recent agreement in the...
IPA’s subsidiary BioStrand Unveils Major Breakthrough in Life Sciences with Advanced Foundation AI Model Utilizing LLM Stacking and HYFT Technology
AIT365 News Desk -
IPA, an artificial intelligence-driven biotherapeutic research and technology company, announced the development of a Foundation AI Model that represents a significant advancement in life sciences research and development. The Company’s model uniquely combines the strengths of Large Language Models (LLMs) through an advanced stacking technique with BioStrand's patented HYFT...
Genesis Therapeutics, a company pioneering generative and predictive artificial intelligence (AI) technologies to develop breakthrough therapeutics for underserved patient populations, announced that Fierce Medtech has named it as one of 2023’s “Fierce 15” medtech companies. The annual special report features the most innovative private companies in the industry.
Genesis has...
Helix Appoints Genentech and Flatiron Health Vet Hylton Kalvaria as SVP of Life Sciences
AIT365 News Desk -
Helix, the leading population genomics company in the nation, announced that Hylton Kalvaria has joined its leadership team as senior vice president (SVP) of Life Sciences. Kalvaria will oversee partnerships leveraging the unique and growing clinico-genomic datasets of Helix with life sciences customers.
Kalvaria brings a wealth of executive experience...
BIOHM Health Inc. Partners with Virginia Tech to Accelerate Bacterial and Fungal Microbiome-Based Product Development and Commercialization through A.I.
AIT365 News Desk -
BIOHM Health Inc., a leading innovator in, and patent holder of, microbiome-based products and ingredients, has announced a partnership with Virginia Tech to further enhance its pioneering Symbiont platform through the use of artificial intelligence (A.I.). Symbiont, which has been peer reviewed in Gastroenterology, is a process which identifies and selects ingredients...
Ibex and PathPresenter Launch Partnership to Accelerate Adoption of AI-powered Digital Pathology
AIT365 News Desk -
Ibex Medical Analytics, the leader in AI-powered cancer diagnostics, and PathPresenter, the global image sharing platform for pathology, announced a partnership to advance the adoption of AI-powered digital pathology. The two companies will work together to support joint customers via an AI-powered digital pathology solution for laboratories, hospitals and health...
PreemptiveAI Emerges From Stealth With a Groundbreaking Biomedical Foundation Model For Health Prediction
AIT365 News Desk -
PreemptiveAI, an innovative AI research and development company driven by a mission to extend human life and boasting multiple scientific breakthroughs, is thrilled to announce its emergence from stealth mode. Based in Seattle, WA and backed by an initial $6.4M in funding, the company is unveiling a revolutionary foundation model aimed at transforming...
Transgene, NEC, and BostonGene Expand Collaboration for Phase I/II Clinical Trial of Neoantigen Cancer Vaccine TG4050
AIT365 News Desk -
Transgene, a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, NEC Corporation, a leader in IT, network and AI technologies and BostonGene Corporation (BostonGene), a leading company in AI-based molecular and immune profiling, announced the expansion of their collaboration for the randomized Phase I/II...